Director Christoph Ziegler Acquires 30,000 Veraxa Biotech Shares at $1.09 Each on October 20, 2026

Director Christoph Samuel Ziegler recently purchased 30,000 ordinary shares of Veraxa Biotech AG (NASDAQ:VRXA) at $1.09 per share on October 20, 2026. This open-market acquisition, detailed in a Form 4 filed with the SEC on October 21, 2026, increases Ziegler's direct ownership to 37,932 shares. No derivative security transactions were involved in this purchase.